Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Trial of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
Conditions
Interventions
Deferiprone oral solution
Placebo
Locations
4
United States
Children's Hospital & Research Center at Oakland
Oakland, California, United States
Klinikum der Universität München
Munich, Germany
Foundation Neurological Institute C. Besta
Milan, Italy
Newcastle University Institute of Human Genetics
Newcastle upon Tyne, United Kingdom
Start Date
December 13, 2012
Primary Completion Date
October 21, 2016
Completion Date
January 11, 2017
Last Updated
July 5, 2019
Lead Sponsor
ApoPharma
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions